Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Devyser LynchFAP NGS

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Devyser LynchFAP1 is the first kit on the market to accurately assess all PMS2 variants!

First commercial kit to include a long-range PCR to unambiguously determine variants in all PMS2 exons.

Devyser LynchFAP is a targeted next-generation sequencing (NGS) assay for the analysis of genes associated with hereditary colon cancer syndromes. The assay enables analysis of sequence variants (SNVs, CNVs, and indels) in 10 selected genes implicated in Lynch syndrome, Familial Adenomatous Polyposis, and MUTYH-Associated Polyposis.

A long-range PCR is incorporated into the simplified workflow to accurately localise variants in all PMS2 exons, including challenging regions homologous to the PMS2CL pseudogene. Devyser LynchFAP NGS, together with its dedicated software, enables fast and intuitive results, including the evaluation of PMS2 gene conversion with PMS2CL.

Genes included:

MLH1 MSH2 MSH6 PMS2 EPCAM
APC MUTYH POLE POLD1 CTNNB1

Watch the webinar on-demand webinar and learn more about Devyser LynchFAP – Devyser I Webinar on Devyser LynchFAP

 

View the LynchFAP NGS Flyer

Download Here >

References

1 Devyser LynchFAP NGS is for research use only (RUO).



Request a Quote

Request Quote

Recent Posts

ZytoVision by Zytomics: Fully automated probes for the BOND™ Systems

Product Portfolio: Prod. No. Product Label Tests (Volume) Z-2315-5-1ML ZytoMation ALK Dual Color Break Apart FISH Probe ●/● up to 20 (5.1 ml) Z-2306-5-1ML ZytoMation…

Read full article

Invivoscribe – LymphoTrack Flex

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.Identifying clonality and determining the frequency of immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements…

Read full article

Invivoscribe – NPM1 MRD Assay now available globally

Invivoscribe’s NPM1 MRD Assay is an NGS-based, targeted, deep-sequencing assay that detects and monitors DNA sequences specific to identified mutations from the primary sample identified at diagnosis with an allelic sensitivity…

Read full article